JESSICA ALIGHIRE: Open Payments
NPI 1043564305 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 62 payments from 28 companies in 2025. Trend: 2023 $881 · 2024 $1,340 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $190 |
| PFIZER INC. | 7 | $173 |
| Teva Pharmaceuticals USA, Inc. | 6 | $141 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $85 |
| Exact Sciences Corporation | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $62 |
| Astellas Pharma US Inc | 3 | $56 |
| Novo Nordisk Inc | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
Products named: VRAYLAR, AUSTEDO XR, XIFAXAN, REXULTI, Cologuard Collection Kit, Kerendia, Veozah, JARDIANCE.
Industry payments across MI — which companies pay providers there.
